Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
Drug Metabolism Reviews|July 25, 2025
Biotransformation research advances - 2024 year in reviewLionel Cheruzel, Upendra A Argikar, Pietro Brunetti, et al.Drug Metabolism Reviews|August 4, 2025
Metabolism of new drug modalities research advances - 2024 year in reviewBin Ma, Upendra A Argikar, Luying Chen, et al.Metabolites|August 25, 2022
Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 CytochromesSamantha V Crosby, Izzeldin Y Ahmed, Laura R Osborn, et al.Drug Metabolism Reviews|July 4, 2024
Bioactivation and reactivity research advances - 2023 year in reviewShuai Wang, Upendra A Argikar, Maria Chatzopoulou, et al.Bioorganic & Medicinal Chemistry Letters|December 26, 2017
Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screenDaniel S Palacios, Erik Meredith, Toshio Kawanami, et al.Drug Metabolism Reviews|August 23, 2023
Bioactivation and reactivity research advances - 2022 year in review‡Shuai Wang, Upendra A Argikar, Lionel Cheruzel, et al.Drug Metabolism Reviews|September 22, 2023
Biotransformation research advances - 2022 year in reviewS Cyrus Khojasteh, Upendra A Argikar, Lionel Cheruzel, et al.Clinical Pharmacology and Therapeutics|July 31, 2018
Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling ApproachesYingying Guo, Xiaoyan Chu, Neil J Parrott, et al.Journal of Medicinal Chemistry|August 4, 2017
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension ModelsKen Yamada, Julian Levell, Taeyong Yoon, et al.Journal of Medicinal Chemistry|June 17, 2017
Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in VivoEdwige Lorthiois, Karen Anderson, Anna Vulpetti, et al.Pageof 12